Hosted on MSN1mon
Johnson & Johnson ketamine-derived nasal spray gets FDA approval for depression, but JNJ stock dips on earningsContinue reading Spravato, which is derived from ketamine, is not a new drug—it ... Despite the approval, Johnson & Johnson’s stock (JNJ) dipped Wednesday after the company’s quarterly ...
Bryan Johnson is a biohacker on a mission to conquer death and has been injecting ketamine into his system to see how it ...
Bryan Johnson, the American entrepreneur renowned for his anti-ageing endeavours, has disclosed the details of his latest ...
In his quest to defy ageing, he has undergone unconventional and radical procedures, including receiving blood transfusions ...
Ketamine, a dissociative anesthetic, has carved itself a spot in the world of mental health care over the past two decades.
Across Lancashire, recorded offences for possession and supply of ketamine rose by nearly 70% from 54 in 2023 to 91 in 2024. ...
Bryan Johnson, an American entrepreneur known for his anti-ageing experiments, recently revealed details of his latest ...
Spravato is a ketamine-derived nasal spray that is FDA-approved for treatment-resistant depression. The Johnson & Johnson drug has been on the market since 2019, but could only be prescribed ...
Bryan Johnson shared details of the study of his brain following the Ketamine injection. (X/@bryan_johnson) The entrepreneur, who created a huge buzz in India recently after he left billionaire ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results